Loading...
Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma
YM155 is an anti-cancer therapy that has advanced into 11 different human clinical trials to treat various cancers. This apoptosis-inducing therapy indirectly affects the protein levels of survivin (gene: Birc5), but the molecular underpinnings of the mechanism remain largely unknown. Synovial sarco...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463023/ https://ncbi.nlm.nih.gov/pubmed/30909651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030408 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|